The Parkinson's Foundation announced July 16 the launch of a nationwide initiative providing free genetic testing for clinically relevant, Parkinson's disease-related genes, the results of which will be used to inform research into precision treatments.
PD GENEration's genetic testing will initially be offered at Columbia University's Irving Medical Center in New York City, then a few more sites within the foundation's Centers of Excellence network. Ultimately, by 2020, the program will expand to a total of about 50 sites, with a goal of testing up to 15,000 people.
Participants will receive the results of their tests, as well as free genetic counseling to better understand the results. The findings will then be used in scientific research to develop personalized medicine for Parkinson's. The tests may also help physicians identify potential subjects for Parkinson's-related clinical trials, further advancing precision treatments for the disease.
"Between 10 and 15 percent of people with Parkinson's have a genetic form of the disease," said James Beck, PhD, chief scientific officer of the foundation. "By better understanding how these people experience symptoms related to the disease and respond to treatments, scientists can begin to build the foundation for precision medicine in PD."
More articles about health IT:
Dell, Microsoft throw millions behind AI startups to 'get a window on innovation'
AT&T partners with IBM for cloud hosting, edge computing: 4 notes
WakeMed launches mobile patient engagement app: 4 things to know